Cardiac Normal Values Assessed by Magnetic Resonance Imaging

Status Recruiting

Clinical Trial Summary

This study carried out a study enrolled healthy volunteers to comprehensively provide age and sex specific reference values of the normal cardiac structure and function of Chinese adults, using the steady-state free precession technique (SSFP) as well as reference values for novel cardiovascular magnetic resonance techniques including myocardial strian and tissue characterization.

Clinical Trial Description

Cardiovascular magnetic resonance (CMR), as a non-invasive and radiation-free examination, can identify the structural and functional abnormalities of various cardiovascular diseases. It is the gold standard for cardiovascular structural and functional measurements, and recommended as a priority examination for cardiovascular diseases by guidelines of the American College of Cardiology (ACC/AHA) and the European College of Cardiology (ESC). The reference standard for cardiovascular structure and function of normal people is the basis for cardiovascular disease study, and plays a vital role in diagnosis, differential diagnosis, and prognosis evaluation. CMR parameters have been shown to provide significant information for the general population and have always been important biomarkers for morbidity and mortality in patients with cardiac pathologies. Although there are relevant reference standards for normal values in the world, there is no standard for normal values of large samples of Chinese people. In addition, most of the normal values are limited to traditional parameters of cardiac structure and function, and there is no normal value standard for novel parameters including myocardial strain and tissue characteristics. Therefore, on the basis of previous works, our group planned to create a cardiovascular MRI reference value database of normal Chinese people through retrospective and prospective recruitment, which will lay a foundation for the early identification and prognosis assessment of cardiovascular diseases, and promote the progress of systematic cardiovascular magnetic resonance studies. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05346094
Study type	Observational
Source	Chinese Academy of Medical Sciences, Fuwai Hospital
Contact	Minjie Lu
Phone	13681042022
Email	coolkan@163.com
Status	Recruiting
Phase
Start date	January 1, 2022
Completion date	June 30, 2027

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05445440` - A Study to Assess the Effects of BMS-986371 on the Drug Levels of Methotrexate in the Presence and Absence of Sulfasalazine	Phase 1
Completed	`NCT03712540` - An Investigational Study of Experimental Medication BMS-986278 Given With the Antibiotic Rifampin in Healthy Participants	Phase 1
Completed	`NCT03649165` - A Study to Evaluate Bioavailability and Food Effect of Selumetinib (AZD6244) in Healthy Male Participants	Phase 1
Completed	`NCT05956002` - A Study to Evaluate the Study Medication (Etrasimod) When Mixed With Food in Healthy Participants	Phase 1
Completed	`NCT05539976` - A Taste Assessment of Iberdomide and Mezigdomide in Healthy Participants
Withdrawn	`NCT04558216` - Evaluation of Effect of Rifampin on the Pharmacokinetics of Vonoprazan in Healthy Participants	Phase 1
Withdrawn	`NCT03007771` - Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia	Phase 1
Completed	`NCT06097390` - A Research Study Looking at New Protein-based Tablets in Healthy Men - Oral Formulation III	Phase 1
Completed	`NCT05546151` - A Study to Assess the Safety and Tolerability of BMS-986322 in Healthy Participants of Japanese Descent	Phase 1
Completed	`NCT05056246` - Study of AMG 133 Administered Subcutaneously in Healthy Japanese and Caucasian Participants	Phase 1
Completed	`NCT04390776` - Bioequivalence Study of PF-06651600 Capsules Relative to Tablets and Estimation of Food Effect on Capsules.	Phase 1
Completed	`NCT05074459` - A Study in Healthy Adults Investigating Eptinezumab Produced by 2 Different Manufacturing Cell Lines	Phase 1
Enrolling by invitation	`NCT06089109` - Creating VIP Corps to Reduce Maternal Deaths	N/A
Completed	`NCT05996250` - Tolerance of an Immersive Virtual Reality Task Evaluating the Spatial Memory of Elderly Subjects	N/A
Completed	`NCT03278080` - Development of Assessment Method for Driving Ability Using Driving Simulator in Healthy Volunteers #1	N/A
Completed	`NCT05064800` - PF-07321332/Ritonavir and Ritonavir on Dabigatran Study in Healthy Participants	Phase 1
Completed	`NCT04471298` - A Study of Qishenyiqi Dripping Pills in Healthy Participants	Phase 1
Completed	`NCT04914936` - A Study to Evaluate the One-way Interaction of Calcium Carbonate, Omeprazole, or Rifampin on ACP-196	Phase 1
Completed	`NCT02563262` - Human Neutral Body Posture in Weightlessness	N/A
Completed	`NCT02882386` - Amino Acid Kinetics in Blood After Consuming Different Milk Protein Supplements	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.